ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,002Medicare Part D Prescriptions Filled, Including Refills

Rank: 158 out of 1206

$678K Total Retail Price of All Prescriptions

Rank: 56 out of 1206

448 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 448 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

19% of this provider’s 448 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

0% of this provider’s 7,137 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
SIMVASTATIN 627 466 1 1
AMLODIPINE BESYLATE 388 292 2 6
HYDROCODONE-ACETAMINOPHEN 371 257 S3 3 7
CITALOPRAM HBR 306 156 4 16
LEVOTHYROXINE SODIUM 304 235 5 2
WARFARIN SODIUM 289 227 6 8
METFORMIN HCL 271 201 7 10
FUROSEMIDE 253 161 8 5
OMEPRAZOLE 230 138 9 3
TRAMADOL HCL 213 125 10 17
LISINOPRIL 202 151 11 4
METOPROLOL TARTRATE 165 104 12 9
ATORVASTATIN CALCIUM 161 134 13 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 147 93 14 27
DONEPEZIL HCL 132 122 15 29
ZOLPIDEM TARTRATE 127 82 16 25
NEXIUM 115 35 17 47
PREDNISONE 114 77 18 28
GLIMEPIRIDE 112 87 19 34
ATENOLOL 110 98 20 14
ALENDRONATE SODIUM 109 94 21 19
TAMSULOSIN HCL 107 94 22 26
POTASSIUM CHLORIDE 107 70 22 12
ADVAIR DISKUS 106 59 24 55
TRICOR 101 79 25 130
MELOXICAM 94 49 26 35
RANITIDINE HCL 94 48 26 23
CELEBREX 91 71 28 84
JANUVIA 87 52 29 87
TRIAMTERENE-HCTZ 86 73 30 33
LYRICA 82 49 31 115
LOSARTAN-HYDROCHLOROTHIAZIDE 81 72 32 60
GABAPENTIN 81 37 32 18
TRAZODONE HCL 78 64 34 37
SULFAMETHOXAZOLE-TRIMETHOPRIM 73 28 35 82
CRESTOR 70 30 36 30
SPIRIVA 69 22 37 66
FENOFIBRATE 68 54 38 56
PROAIR HFA 67 42 39 49
CYMBALTA 66 20 40 63
ALLOPURINOL 66 29 40 24
SERTRALINE HCL 63 54 42 22
FLUTICASONE PROPIONATE 61 48 43 42
ACTOS 61 58 43 98
CARVEDILOL 60 41 45 32
HYDROCHLOROTHIAZIDE 59 27 46 11
OXYCODONE HCL 58 27 S2 47 107
SYNTHROID 57 47 48 94
METOPROLOL SUCCINATE 57 27 48 15
AZITHROMYCIN 55 33 50 46
EXFORGE 53 26 51 283
DOXYCYCLINE HYCLATE 53 45 51 103
PREMARIN 53 0 R 51 147
BYSTOLIC 52 45 54 109
BISOPROLOL-HYDROCHLOROTHIAZIDE 52 39 54 108
FENTANYL 50 20 S2 56 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 26, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.